Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy

Acta Neurologica Belgica

Volumn 102, Issue 3, 2002, Pages 122-126

  Geda, G ^a   Caksen H ^a   Icagasioglu D ^a  

^a K Karabekir C   (Turkey)

Author keywords

B12; Child; Folic acid; Lipid; Valproate

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMOTRIGINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; TRIACYLGLYCEROL; VALPROIC ACID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; FEMALE; GROUPS BY AGE; HUMAN; LIPID BLOOD LEVEL; LIPID COMPOSITION; LONG TERM CARE; MALE; STATISTICAL PARAMETERS; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 0036400205     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. AYNACI F. M., ORHAN F., ÖREM A., YILDIRMIŞ S., GEDIK Y. Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood. J. Child. Neurol., 2001, 16 : 367-369.
2. BERLIT P., KRAUSE K. H., HEUCH C. C., SHELLENBERG B. Serum lipids and anticonvulsants. Acta Neurol. Scand., 1982, 66 : 328-334.
3. CALANDRE E. P., RODRIGUEZ-LOPEZ C., BLATQUEZ A., CANO D. Serum lipids, lipoproteins and apolipoproteins A an B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol. Scand., 1991, 83 : 250-253.
4. DASTUR D. K., DAVE U. P. Effect of prolonged anticonvulsant medication in epileptic patients : serum lipids, vitamins B6, B12, and folic acid, proteins, and fine structure of liver. Epilepsia, 1987, 28: 147-159.
5. DEMIRCIOGLU S., SOYLU A., DIRIK E. Carbamazepine and valproic acid : effects on the serum lipids and liver functions in children. Pediatr Neurol., 2000, 23 142-146.
6. EIRIS J., NOVO-RODRIGUEZ M. I., DEL RIO M., MESEGUER P., DEL RIO M. C., CASTRO-GAGO M. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res., 2000, 41 : 1-7.
7. EIRIS J. M., LOJO S., DEL RIO M. C., NOVO I., BRAVO M., PAVON P., CASTRO-GAGO M. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology, 1995, 45 : 1155-1157.
8. FRANK O., BAKER H., LEAVY C. M. Vitamin binding capacity of experimentally injured liver. Nature, 1964, 203 : 302-303.
9. FRANZONI E., DESCOVICH G. C., SALVIOLI G. P. Total cholesterol, high density lipoprotein and triglycerides in children receiving antiepileptic drugs. Epilepsia, 1992, 33 : 932-935.
10. FRÖSCHER W., MAIER V., LAAGE M., et al., Folate deficiency, anticonvulsant drugs, and psychiatric morbidity. Clin. Neuropharmacol., 1995, 18 : 165-182.
11. GANICK D. J., SUNDER T., FINLEY J. L. Severe hematologic toxicity of valproic acid. A report of four patients. Am. J. Pediatr Hematol. Oncol., 1990, 12 : 80-85.
12. HAUSER E., SEIDL R., FREILINGER M., MALE C., HERKNER K. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy. Brain Dev., 1996, 18 : 105-109.
13. HELDENBERG D., HAREL S., HOLTZMAN M., LEVTOW O., TAMIR I. The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children. Neurology, 1983, 33 : 510-513.
14. ISOJARVI J. I., RATTYA J., MYLLYLA V. V., KNIP M., KOIVUNEN R., PAKARINEN A. J., TEKAY A., TAPANAINEN J. S. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann. Neurol., 1998, 43 : 446-451.
15. ISOJARVI J. I., TAUBOLL E., PAKARINEN A. J., VAN PARYS J., RATTYA J., HARBO H. F., DALE P. O., FAUSER B. C., GJERSTAD L., KOIVUNEN R., KNIP M., TAPANAINEN J. S. Altered ovarian function and cardiovascular risk factors in valproate-treated women. Am. J. Med., 2001, 111 : 290-296.
16. KISHI T., FUJITA N., EGUCHI T., UEDA K. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy. J. Neurol. Sci., 1997, 145 : 109-112.
17. KRAUSE K. H., BONJOUR J. P., BERLIT R, KYNAST G., SCHMIDT-GAYK H., SCHELLENBERG B. Effect of long-term treatment with antiepileptic drugs on the vitamin status. Drug Nutr. Interact., 1988, 5: 317-343.
18. MAY R. B., SUNDER T. R. Hematologic manifestations of long-term valproate therapy. Epilepsia, 1993, 34: 1098-1101.
19. NIMMO G. R., RYAN M..J., CHALMERS N., PATRICK A. W. The clinical importance of subnormal folate levels in epileptic patients on anticonvulsant therapy. Scott. Med. J., 1987, 32 : 171-172.
20. ONO H., SAKAMOTO A., EGUCHI T., FUJITA N., NOMURA S., UEDA H., SAKURA N., UEDA K. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabolism, 1997, 46 : 959-962.
21. RATTYA J., VAINIONPAA L., KNIP M., LANNING P., ISOJARVI J. I. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics, 1999, 103 : 588-593.
22. REDDY M. N. Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol and apolipoproteins A and B in children with epilepsy. Proc. Sco. Exp. Biol. Med., 1985, 180: 359-363.
23. STEPHEN L. J., KWAN P., SHAPIRO D., DOMINICZAK M., BRODIE M. J. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia, 2001, 42: 1002-1006.
24. SUDDEN T. R., MAY R. B. Valproic acid-induced macrocytosis. Epilepsia, 1988, 5 : 670.
25. SÖZÜER D. T., ATAKIL D., DOGU O., BAYBAS S., ARPACI B. Serum lipids in epileptic children treated with carbamazepine and valproate. Eur. J. Pediatr., 1997, 156 : 565-567.
26. TAMURA T., AISO K., JOHNSTON K. E., BLACK L., FAUGHT E. Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy. Epilepsy Res., 2000, 40 : 7-15.
27. VERROTTI A., DOMIZIO S., ANGELOZZI B., SABATINO G., MORGESE G., CHIARELLI F. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J. Paediatr. Child. Health, 1997, 33 : 242-245.
28. VERROTTI A., BASCIANI F., DOMIZIO S., SABATINO G., MORGESE G., CHIARELLI F. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr. Neurol., 1998, 19 : 364-367.
29. VERROTTI A., PASCARELLA R., TROTTA D., GIUVA T., MORGESE G., CHIARELLI F. Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res., 2000, 41 : 253-257.
30. YALÇIN E., HASSANZADEH A., MAWLUD K. The effects of long-term anticonvulsive treatment on serum lipid profile. Acta Paediatr., Jpn., 1997, 39 : 342-345.
31. YILMAZ E., DOSAN Y., GÜRGÖZE M. K., GÜNGÖR S. Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children. Acta Neurol. Belg., 2001, 101 : 217-220.